PRSR $10.07 0.0497%
CALM $47.21 -1.4405%
WSBN.L $2.40 0%
SO.PA $143.00 0%
GRNR $20.75 0.973241%
GLDD $6.06 -1.8639%
2129.HK $0.10 -3.7383%
JWAC $6.23 21.6797%
BIOTU $10.14 0%
CTAQW $0.00 0%
NVTSW $2.10 0%
BAF.L $18.95 14.8485%
6063.HK $0.06 0%
ALP.PA $17.55 0%
CL2.PA $3 511.00 1.0505%
FCAP $24.00 0.2084%
3816.HK $0.22 3.3654%
1542.HK $2.58 -1.52672%
LQDH $90.69 0.0074%
LWAC $16.98 0%
ARGX.BR $370.20 0.5159%
TFI.PA $7.16 0.14%
LDP $16.23 -0.734%
PCEU.PA $26.56 0.492%
GLBZ $7.68 -0.5699%
ERC $8.80 -0.9009%
SMTI $41.30 3.2758%
GATEW $0.03 -13.0667%
XZMD.L $7.07 0%
CACC $426.21 -0.788%
CCS $66.60 -1.1283%
0ELV.L $17.22 0.7445%
MYSZ $1.21 0.8333%
THMA $9.30 0%
MMIT.L $123.50 0%
ESPR $1.52 2.0134%
NEO $19.10 -3.6813%
MLC.IR $4.96 0.4049%
KXIN $0.30 -3.0596%
PXLW $1.52 -2.5641%
SOL.MC $4.41 0.41%
0K6M.L $4.21 -2.7296%
VDPA.L $52.97 -0.2073%
ATGE $41.12 -0.2789%
CHAA-UN $10.14 0%
VTN $10.11 -0.4618%
6080.HK $0.08 0%
IAC $57.79 -2.0652%
PXH $18.39 -1.4129%
FRHC $80.36 -0.9247%
0O2W.L $30.49 -0.1296%
LOOP.L $2.70 0%
RNER $4.99 0%
TIOAU $10.25 0%
ALNA $0.08 0%
FEQD.L $5.76 0.174%
QTS $77.98 0%
1262.HK $0.26 0%
BHGU.L $19.90 0%
VULC3.SA $14.47 -2.2297%
NBPU.L $19.50 -2.5%
GSQB $10.40 0%
VHYA.L $61.31 -0.1466%
ALD $44.39 0%
KAL $1.12 0%
2883.HK $8.53 -1.7281%
PGOO.L $53.00 2.9126%
NM-PG $19.13 0.1046%
MRVE3.SA $8.91 -2.1954%
LGND $75.70 -2.5865%
HETA4.SA $4.31 3.3573%
FLO.PA $21.00 0%
0P0000TKZG.L $15 329.80 0.3982%
KVSA $10.22 0%
SMTPC.PA $26.80 0%
0I0H.L $14.64 -0.0546%
PBD $18.27 -0.4903%
LFC $7.25 0%
U09.SI $0.21 0%
EGRP.L $1 700.60 0%
SGLN.L $3 143.00 0.0796%
BLMN $22.93 1.1248%
MLCAC.PA $15.40 0%
KFRC $56.58 1.3979%
COCB.L $96.14 0.1719%
9955.HK $9.35 0%
VOX $97.73 -0.4482%
0IQK.L $38.49 -0.4475%
LATNU $10.96 0%
MAA $152.52 -0.3984%
HEDK.L $28.38 0.3714%
ALL-PH $23.21 -0.7696%
ALBIZ.PA $5.86 0%
UAL $44.45 -1.4086%
MILN $29.52 -1.056%
0536.HK $0.97 -2.0202%
3329.HK $0.47 4.4944%
DSG.L $20.00 0%
MHLD $2.03 -0.4902%
BIDI11.SA $10.40 0%
Eng
Логотип
Eng
Лого

Fusion Antibodies plc FAB.L

$39.50

+$2.11 (5.33%)
На 18:02, 12 мая 2023

Ранг: 3

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    10405960.00000000

  • week52high

    110.00

  • week52low

    28.00

  • Revenue

    4799000

  • P/E TTM

    -759

  • Beta

    0.24045800

  • EPS

    -0.07000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    09 дек 2022 г. в 10:00

Описание компании

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек